Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (3S, 4R) 4 (4 fluorophenyl) 3 hydroxymethyl 1 R piperidine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101974604B details a novel ionic liquid biocatalysis route for paroxetine intermediates, offering high optical purity and reduced environmental impact for reliable supply chains.
Patent CN101974604A reveals a green enzymatic route for paroxetine intermediates using ionic liquids, offering high purity and reduced environmental impact for API manufacturing.